Olympus Named to Dow Jones Best-in-Class World Index
for the Fifth Consecutive Year

May 8, 2026

---

Olympus Corporation (Olympus), a global MedTech company committed to making people’s lives healthier, safer and more fulfilling, today announced its inclusion in the Dow Jones Best-in-Class (DJBIC) Indices¹, one of the most globally recognized benchmarks for corporate sustainability. This marks the fifth consecutive year Olympus has been named on the DJBIC World Index. The company has also earned a place on the DJBIC Asia Pacific Index¹ for the seventh consecutive year.

Furthermore, Olympus has been ranked within the Top 5% of its industry in the Sustainability Yearbook 2026, published by S&P Global. Olympus was noted with Distinction, an honor given to companies with outstanding sustainability performance. A trophy was recently presented to the company at an award ceremony held in Tokyo in recognition of this achievement.

About DJBIC Indices and The Sustainability Yearbook

DJBIC Indices are corporate sustainability evaluation indices for environmental, social, and governance (ESG) investment. Jointly developed by S&P Dow Jones Indices and RobecoSAM, the DJBIC Indices track the financial performance of leading companies according to ESG criteria. In 2025, 317 companies were selected as DJBIC World members from approximately 3,600 companies worldwide. Olympus is one of the 7 companies to have been included in the Health Care Equipment & Suppliers sector.

The Sustainability Yearbook showcases the world's best-performing companies in terms of sustainability based on the Corporate Sustainability Assessment (CSA). In the 2026 edition, out of over 9,200 companies assessed, only 135 companies reached the Top 5% status. Olympus’ inclusion reflects its strong standing as a leader in sustainability both globally and within Japan.

This fiscal year, Olympus was recognized for achieving 100% renewable energy at its manufacturing site in Vietnam , as well as for its disclosures aligned with the recommendations of the Task Force on Climate-related Financial Disclosures and the Task Force on Nature-related Financial Disclosures . As a result, Olympus received the highest rating in the “Climate Strategy” category within the Health Care Equipment & Supplies sector.

In addition, the company earned strong evaluations across several other areas, including “Materiality,” “Information Security,” “Environmental Policy and Management Systems,” and “Access to Healthcare.”

ESG Initiatives

In addition to the DJBIC World and DJBIC Asia Pacific Index, Olympus was also recently named to the FTSE4Good Index Series and FTSE Blossom Japan Index. For more information on Olympus’ ESG initiatives, please refer to the Integrated Report 2025 and visit the Sustainability page on our website.

Olympus will continue to place ESG at the core of our management to contribute to the realization of a sustainable society and to fulfill Our Purpose of “making people's lives healthier, safer and more fulfilling”.

1. Renamed from the “Dow Jones Sustainability World Index” and the “Dow Jones Sustainability Asia Pacific Index” as of February 2025.

About Olympus

At Olympus, we are committed to Our Purpose of making people’s lives healthier, safer and more fulfilling. As a global medical technology company, we partner with healthcare professionals to provide innovative solutions and services for early detection, diagnosis and minimally invasive treatment, aiming to improve patient outcomes by elevating the standard of care in targeted disease states.
For more than 100 years, Olympus has pursued a goal of contributing to society by producing products designed with the purpose of delivering optimal outcomes for its customers around the world. For more information, visit https://www.olympus-global.com and follow our LinkedIn account.